Sharif Tabebordbar On Raising $51 Million With His Team To Transform Pain Into Hope For Muscle Wasting Diseases

DealMakers: Entrepreneur | Startups | Venture Capital - Podcast tekijän mukaan Alejandro Cremades

kokeile Podimo ilmaiseksi 30! päivän ajan

kokeile Podimo ilmaiseksi 30! päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

 Sponsored

Kategoriat:

Talous

In a recent interview with Sharif Tabebordbar, co-founder of Kate Therapeutics, we delved into his personal journey, scientific endeavors, and the establishment of a groundbreaking company focused on developing gene therapies for genetic muscle diseases.

Visit the podcast's native language site